Production of endogenous antibiotics in articular cartilage

Arthritis and Rheumatism

Volumn 50, Issue 11, 2004, Pages 3526-3534

  Varoga, Deike ^a   Pufe, Thomas ^a,d   Harder, Jürgen ^a   Meyer Hoffert, Ulf ^a   Mentlein, Rolf ^a   Schröder, Jens Michael ^a   Petersen, Wolf J ^a   Tillmann, Bernhard N ^a   Proksch, Ehrhardt ^a   Goldring, Mary B ^b   Paulsen, Friedrich P ^c  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b HARVARD INSTITUTES OF MEDICINE   (United States)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA DEFENSIN 2; BETA DEFENSIN 3; BETA DEFENSIN 4; CYTOKINE; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BACTERIAL ARTHRITIS; CARTILAGE CELL; CELL CULTURE; CONTROLLED STUDY; DEFENSE MECHANISM; GRAM NEGATIVE INFECTION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INOCULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSEUDOMONAS AERUGINOSA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; STAPHYLOCOCCUS AUREUS; SUPERNATANT; UPREGULATION;

ADULT; ANIMALS; ANTI-INFECTIVE AGENTS; ARTHRITIS, INFECTIOUS; BETA-DEFENSINS; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; HUMANS; LIPOPOLYSACCHARIDES; MICE; OSMOLAR CONCENTRATION; PSEUDOMONAS INFECTIONS; STAPHYLOCOCCAL INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 8444224650     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20605     Document Type: Article

References (40)

1. Hultgren OH, Stenson M, Tarkowski A. Role of IL-12 in Staphylococcus aureus-triggered arthritis and sepsis. Arthritis Res 2001;3:41-7.
2. Ryan MJ, Kavanagh R, Wall PG, Hazleman BL. Bacterial joint infections in England and Wales: analysis of bacterial isolates over a four year period. Br J Rheumatol 1997;36:370-3.
3. Conforti L, Petrovic M, Mohammad D, Lee S, Ma Q, Barone S, et al. Hypoxia regulates expression and activity of Kv1.3 channels in T lymphocytes: a possible role in T cell proliferation. J Immunol 2003;170:695-702.
4. Harder J, Bartels J, Christophers E, Schroder JM. A peptide antibiotic from human skin [letter]. Nature 1997;387:861.
5. Dorschner RA, Lin KH, Murakami M, Gallo RL. Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response. Pediatr Res 2003;53:566-72.
6. Schroder JM, Harder J. Human β-defensin-2. Int J Biochem Cell Biol 1999;31:645-51.
7. Singh PK, Jia HP, Wiles K, Hesselberth J, Liu L, Conway BA, et al. Production of β-defensins by human airway epithelia. Proc Natl Acad Sci U S A 1998;95:14961-6.
8. Harder J, Meyer-Hoffert U, Teran LM, Schwichtenberg L, Bartels J, Maune S, et al. Mucoid Pseudomonas aeruginosa, TNF-α, and IL-1-β, but not IL-6, induce human β-defensin-2 in respiratory epithelia. Am J Respir Cell Mol Biol 2000;22:714-21.
9. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;415:389-95.
10. Tsutsumi-Ishii Y, Nagaoka I. NF-κB-mediated transcriptional regulation of human β-defensin-2 gene following lipopolysaccharide stimulation. J Leukoc Biol 2002;71:154-62.
11. Bensch KW, Raida M, Magert HJ, Schulz-Knappe P, Forssmann WG. HBD-1: a novel β-defensin from human plasma. FEBS Lett 1995;17:368:331-5.
12. Harder J, Bartels J, Christophers E, Schroder JM. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem 2001;276:5707-13.
13. Garcia JR, Krause A, Schulz S, Rodriguez-Jimenez FJ, Kluver E, Adermann K, et al. Human β-defensin 4: a novel inducible peptide with a specific salt-sensitive spectrum of antimicrobial activity. FASEB J 2001;15:1819-21.
14. Yang D, Chertov O, Bykovskaia SN, Chen Q, Buffo MJ, Shogan J, et al. β-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525-8.
15. Sorensen OE, Cowland JB, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003;170:5583-9.
16. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, et al. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003;11:1665-72.
17. Bals R, Wang X, Meegalla RL, Wattler S, Weiner DJ, Nehls MC, et al. Mouse β-defensin 3 is an inducible antimicrobial peptide expressed in the epithelia of multiple organs. Infect Immun 1999;67:3542-7.
18. Yamaguchi Y, Nagase T, Makita R, Fukuhara S, Tomita T, Tominaga T, et al. Identification of multiple novel epididymis-specific β-defensin isoforms in humans and mice. J Immunol 2002;169:2516-23.
19. Morrison GM, Davidson DJ, Dorin JR. A novel mouse βa defensin, Defb2, which is upregulated in the airways by lipopolysaccharide. FEBS Lett 1999;442:112-6.
20. Jia HP, Wowk SA, Schutte BC, Lee SK, Vivado A, Tack BF, et al. A novel murine β-defensin expressed in tongue, esophagus, and trachea. J Biol Chem 2000;275:33314-20.
21. Burd RS, Furrer JL, Sullivan J, Smith AL. Murine β-defensin-3 is an inducible peptide with limited tissue expression and broad-spectrum antimicrobial activity. Shock 2002;18:461-4.
22. Paulsen F, Pufe T, Petersen W, Tillmann B. Expression of natural peptide antibiotics in human articular cartilage and synovial membrane. Clin Diagn Lab Immunol 2001;8:1021-3.
23. Paulsen F, Pufe T, Conradi L, Varoga D, Tsokos M, Papendieck J, et al. Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes. J Pathol 2002;198:369-77.
24. Goldring MB, Birkhead JR, Suen LF, Yamin R, Mizuno S, Glowacki J, et al. Interleukin-1 β-modulated gene expression in immortalized human chondrocytes. J Clin Invest 1994;94:2307-16.
25. Loeser R, Sadiev S, Tan L, Goldring MB. Integrin expression by primary and immortalized human chondrocytes: evidence of a differential role for α1β1 and α2β1 integrins mediating chondrocyte adhesion to types II and VI collagen. Osteoarthritis Cartilage 2000;8:96-105.
26. Osaki M, Tan L, Choy BK, Yoshida Y, Auron PE, Cheah KS, et al. The TATA-containing core promoter of the type II collagen gene (COL2A1) is the target of interferon-γ-mediated inhibition in human chondrocytes: requirement for Stat1α, Jak1, and Jak2. Biochem J 2003;369:103-15.
27. Parker WL, Goldring MB, Philip A. Endoglin is expressed on human chondrocytes and forms a heteromeric complex with betaglycan in a ligand and type II TGF-β receptor independent manner. J Bone Miner Res 2003;18:289-302.
28. Tan L, Peng H, Osaki M, Choy BK, Auron PE, Sandell LJ, et al. Egr-1 mediates transcriptional repression of COL2A1 promoter activity by interleukin-1β. J Biol Chem 2003;278:17688-700.
29. Grall F, Gu X, Tan L, Cho JY, Inan MS, Pettit A, et al. Responses to the proinflammatory cytokines interleukin-1 and tumor necrosis factor α in cells derived from rheumatoid synovium and other joint tissues involve nuclear factor κB-mediated induction of the Ets transcription factor ESE-1. Arthritis Rheum 2003;48:1249-60.
30. Deng GM, Nilsson IM, Verdrengh M, Tarkowski A. Intraarticularly localized bacterial DNA containing CpG motifs induces arthritis. Nat Med 1999;5:702-5.
31. Liu L, Roberts AA, Ganz T. By IL-1 signaling, monocyte-derived cells dramatically enhance the epidermal antimicrobial response to lipopolysaccharide. J Immunol 2003;170:575-80.
32. Bals R, Wang X, Wu Z, Freeman T, Bafna V, Zasloff M, et al. Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest 1998;102:874-80.
33. Becker MN, Diamond G, Verghese MW, Randell SH. CD-14-dependent lipopolysaccharide-induced β-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 2000;275:29731-6.
34. Valore EV, Park CH, Quale AJ, Wiles KR, McCray PB, Ganz T. Human β-defensin-1: an antimicrobial peptide of urogenital tissue. J Clin Invest 1998;101:1633-42.
35. O'Neil DA, Porter EM, Elewaut D, Anderson GM, Eckmann L, Ganz T, et al. Expression and regulation of the human β-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol 1999;163:6718-24.
36. Spitznagel JK. Antibiotic proteins of human neutrophils. J Clin Invest 1990;86:1381-6.
37. Harder J, Schroder JM. RNase-7, a novel innate immune defense antimicrobial protein of healthy human skin. J Biol Chem 2002;277:46779-84.
38. Ong PY, Ohtake T, Brandt C, Strickland I, Boguniewicz M, Ganz T, et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002;347:1151-60.
39. Putsep K, Carlsson G, Boman HG, Andersson M. Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study. Lancet 2002;360:1116-7.
40. Salzman NH, Ghosh D, Huttner KM, Paterson Y, Bevins CL. Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin. Nature 2003;422:522-6.